Related Experiment Video
Updated: May 16, 2025
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Impact of Bridged Nucleic Acid Positions within Blocking Oligonucleotides on DNA Amplification Inhibition in
Takuma Yamashita1, Yoshinori Tsukumo1, Takenori Yamamoto1
1Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.
Abstract:
Detecting low-frequency genetic mutations is crucial for genetic testing, especially in cancer diagnostics. Wild-type blocking PCR identifies these genetic mutations using a blocking oligonucleotide that is fully complementary to wild-type DNA. The blocking oligonucleotide selectively binds to wild-type DNA, inhibiting its amplification by DNA polymerase and allowing preferential amplification of mutant DNA. Bridged nucleic acids (BNAs), with high binding affinities for cDNA, are often incorporated into the blocking oligonucleotide to enhance inhibition. However, the effects of BNA positioning within the blocking oligonucleotide on wild-type DNA amplification inhibition are poorly understood. To address this issue, we evaluated the effects of different BNA positions on amplification inhibition efficacy by comparing blocking oligonucleotides with varying numbers of BNAs at the 5' end, 3' end, and central region. Results indicated that BNAs at the 5' end enhanced the inhibition efficacy, whereas BNAs at the 3' end notably diminished the inhibition efficacy. Likewise, increasing the number of BNAs in the central region generally decreased the inhibition efficacy. This is one of the first studies to report the importance of BNA positioning in the amplification inhibition efficacy of blocking oligonucleotides.
Insights
Optimizing bridged nucleic acid (BNA) placement in blocking oligonucleotides significantly improves wild-type DNA blocking during PCR. BNAs at the 5' end enhance inhibition, while 3' placement reduces it, crucial for genetic mutation detection.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Detecting low-frequency genetic mutations is vital for diagnostics, particularly in oncology.
- Wild-type blocking PCR utilizes blocking oligonucleotides to inhibit wild-type DNA amplification, enabling mutant DNA detection.
- Bridged nucleic acids (BNAs) enhance blocking oligonucleotide binding affinity but their positional effects are unclear.
Purpose of the Study:
- To investigate the impact of BNA positioning within blocking oligonucleotides on wild-type DNA amplification inhibition.
- To determine optimal BNA placement for maximizing the efficacy of wild-type blocking PCR.
Main Methods:
- Synthesized blocking oligonucleotides with varying BNA numbers and positions (5' end, 3' end, central region).
- Evaluated amplification inhibition efficacy using quantitative PCR assays.
- Compared the performance of different BNA-modified blocking oligonucleotides.
Main Results:
- BNAs positioned at the 5' end of blocking oligonucleotides significantly enhanced inhibition of wild-type DNA amplification.
- BNAs at the 3' end markedly reduced inhibition efficacy.
- Increasing BNA numbers in the central region generally decreased inhibition effectiveness.
Conclusions:
- BNA positioning is a critical factor influencing the efficacy of wild-type blocking oligonucleotides.
- 5'-end BNA incorporation is optimal for enhancing amplification inhibition in wild-type blocking PCR.
- This study provides novel insights into optimizing blocking oligonucleotide design for sensitive genetic mutation detection.
